This book focuses on bladder cancer pathology, including primary bladder malignancies and other tumor varieties, with an emphasis on diagnostic pitfalls and clinical relevance. It also describes normal bladder histology, benign abnormalities with cancer mimickers, and cancer carcinogenesis, which are important subject matter for understanding bladder cancers, correct diagnosis, and differential diagnoses. Accurate diagnosis of bladder cancer plays a central role in daily pathology practice, clinical management, and prognosis. Advances in immunohistochemistry and molecular pathology have enhanced the accuracy of cancer pathology diagnoses. In addition to covering the anatomic and histologic features of bladder tumors, this book also reviews recent molecular and immunohistochemical advances in these areas. Recently updated clinical management information is also presented in this book. Written by experts in the field, Urinary Bladder Pathology serves as a useful resource for practicing pathologists, pathology trainees, and other health professionals who treat patients with bladder cancers.
Edited by:
Haijun Zhou,
Charles C. Guo,
Jae Y. Ro,
MD,
PhD
Imprint: Springer Nature Switzerland AG
Country of Publication: Switzerland
Edition: 2021 ed.
Dimensions:
Height: 254mm,
Width: 178mm,
Weight: 529g
ISBN: 9783030715113
ISBN 10: 3030715116
Pages: 259
Publication Date: 02 May 2022
Audience:
Professional and scholarly
,
Undergraduate
Format: Paperback
Publisher's Status: Active
Introduction.- Normal histology and anatomy of urinary bladder.- Flat epithelial lesion: reactive atypia, atypia of unknown significance, dysplasia and carcinoma in situ.- Papillary tumors.- Invasive urothelial carcinoma.- Variants of urothelial carcinoma.- Other types of carcinoma.- Mesenchymal tumors.- Neuroendocrine tumors.- Lymphoreticular neoplasms.- Metastatic tumors.- Cytology.- Radiologic findings.- Molecular pathology.- Surgical treatment.- Medical treatment with targeted therapy.- How to generate pathology findings.- AJCC staging.- Conclusion and Remarks.
Haijun ZhouDepartment of Pathology and Genomic MedicineHouston Methodist HospitalHouston, TXUSA Charles C. GuoDepartment of PathologyThe University of Texas MD Anderson Cancer CenterHouston, TXUSA Jae Y. RoDepartment of Pathology and Genomic Medicine Weill Medical College of Cornell University / Houston Methodist HospitalHouston, TXUSA
